Rubicon Organics #shorts s #stockmarket #stocks

New vaccine candidate shows promise for protecting against Lassa fever

Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)

September 12, 2024

Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.”

May 17, 2024

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Annual Results 22.02.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc.

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.